GADx’s BotrytisAlert now detects fungal crop pathogen across several critical points in wine production

Global Access Diagnostics (GADx), a social enterprise and leading developer of lateral flow and rapid diagnostic technologies, today announced it has expanded the applications of its low-cost, rapid diagnostic test, BotrytisAlert.

Q&A: FDA medical policy chief talks decentralized trial guidance, improving diversity

The FDA’s director of its Office of Medical Policy wants trial sponsors to keep participant experiences top-of-mind in their decentralized designs. Endpoints News sat down

June 26, 2024

Largest study using machine learning in neuroimaging sets new benchmark for major depression diagnosis

A benchmark classification of major depressive disorder (MDD) using machine learning (ML).

January 15, 2024

California bans controversial ‘excited delirium’ diagnosis

California is the first state to ban doctors and medical examiners from attributing deaths to the controversial diagnosis known as “excited delirium,” which a human

October 12, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.